Tiziana Life Sciences (TLSA) announced the withdrawal of the proposed public offering of common shares due to market conditions.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Initiates Phase 2 Alzheimer’s Trial with Innovative Approach
- Tiziana Life Sciences to dose first patient in Phase 2 Alzheimer’s trial
- Tiziana Life Sciences Announces Spinout of IL-6 Asset into New Company
- Tiziana Life Sciences plans to spinout IL-6 asset into separate listed company
- Tiziana Life Sciences’ Nasal Foralumab Trial Joins ALS MyMatch Program